[1]
NM Al-Khero, K. 2018. Effect of tyrosine kinase inhibitor in patients with chronic myeloid leukemia (cytogenetic, molecular response) in Mosul. Annals of the College of Medicine, Mosul. 40, 2 (Dec. 2018), 1–8. DOI:https://doi.org/10.33899/mmed.2018.160000.